(Q54562040)
Statements
A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer. (English)
Hope Rugo
Erica L Mayer
Jean-Francois Baurain
Joseph Sparano
Lewis Strauss
Mario Campone
Pierre Fumoleau
Ahmad Awada
Oumar Sy
Antonio Llombart-Cussac
8 September 2011
17
21
6897-6904